Thrombosis, both venous and arterial, is a leading cause of morbidity and mortality in
patients with cancer. Studies on the molecular basis of cancer-associated thrombophilia …

Venous thromboembolism (VTE) is a common complication in patients with cancer and
portends a poor prognosis. Our understanding of the underlying pathophysiology of VTE in …

Thromboembolic complications represent the second leading cause of death for cancer
patients. Even though the correlation between cancer and a hypercoagulable state has …

Patients with cancer may display many types of hemostatic disorders that significantly
contribute to morbidity and mortality in this disease. A complex coagulopathy develops in …

The close relationship between cancer and thrombosis is known since more than a century.
Venous thromboembolism (VTE) may be the first manifestation of an occult malignancy in an …

Cancer-associated thrombosis is a major cause of mortality in cancer patients, the most
common type being venous thromboembolism (VTE). Several risk factors for developing …

There is strong evidence linking venous thromboembolic events and malignancy.
Laboratory markers of coagulation activation such as thrombin–antithrombin complex or …

Acute thrombotic events can unveil occult cancer, as they are its first manifestation in about
20 to 30% of all cases. Malignancy interacts in an intricate way with the hemostatic system …

Thrombosis is a major cause of morbidity and mortality in cancer patients. The pathogenesis
of blood coagulation activation in oncological patients is complex and involves both clinical …

In this review we summarize the causes of cancer related thrombosis as well as modern
treatment approaches. Malignancy as a risk factor for thromboembolism is becoming …